A Phase 2 , Multicenter , Double-Blind , Placebo-Controlled Comparator Study of 2 Doses of LY2140023 Versus Placebo in Patients With DSM-IV-TR SchizophreniaClinicalTrials.gov identifier : NCT01086748 .